Adenovirus facilitation of molecular conjugate-mediated gene transferCURIEL, D. T.Progress in medical virology. 1993, Vol 40, pp 1-18, issn 0079-645XArticle

Considerations and challenges for the achievement of targeted gene deliveryCURIEL, D. T.Gene therapy (Basingstoke). 1999, Vol 6, Num 9, pp 1497-1498, issn 0969-7128Article

High-efficiency gene transfer employing adenovirus-polylysine-DNA complexesCURIEL, D. T.Natural immunity. 1994, Vol 13, Num 2-3, pp 141-164, issn 1018-8916Article

Replicative adenoviruses for cancer therapyALEMANY, R; BALAGUE, C; CURIEL, D. T et al.Nature biotechnology. 2000, Vol 18, Num 7, pp 723-727, issn 1087-0156Article

Conditionally replicative adenoviruses for cancer therapyRANCOURT, C; CURIEL, D. T.Advanced drug delivery reviews. 1997, Vol 27, Num 1, pp 67-81, issn 0169-409XArticle

Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vectorREYNOLDS, P. N; DMITRIEV, I; CURIEL, D. T et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 7, pp 1336-1339, issn 0969-7128Article

Gene therapy for cancerGOMEZ-NAVARRO, J; CURIEL, D. T; DOUGLAS, J. T et al.European journal of cancer (1990). 1999, Vol 35, Num 6, pp 867-885, issn 0959-8049Article

Gene therapy strategies for AIDS-related malignanciesCURIEL, T. J; PICHE, A; KASONO, K et al.Gene therapy (Basingstoke). 1997, Vol 4, Num 12, pp 1284-1288, issn 0969-7128Article

Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cellsHUANG, D; PEREBOEV, A. V; CURIEL, D. T et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 4, pp 298-308, issn 0969-7128, 11 p.Article

Evolving gene therapy approaches for osteosarcoma using viral vectors : ReviewWITLOX, M. A; LAMFERS, M. L; WUISMAN, P. I. J. M et al.Bone (New York, NY). 2007, Vol 40, Num 4, pp 797-812, issn 8756-3282, 16 p.Article

Transkriptionales Targeting zur zielgerichteten Krebsgentherapie des Mammakarzinoms = A novel transcriptional targeting strategy for breast cancer gene therapyBREIDENBACH, M; RIMBACH, S; RATH, W et al.Geburtshilfe und Frauenheilkunde. 2005, Vol 65, Num 2, pp 186-191, issn 0016-5751, 6 p.Article

A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinomaKANERVA, A; BAUERSCHMITZ, G. J; YAMAMOTO, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 6, pp 552-559, issn 0969-7128, 8 p.Article

Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinomaBARKER, S. D; DMITRIEV, I. P; NETTELBECK, D. M et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 14, pp 1198-1204, issn 0969-7128, 7 p.Article

Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritisSMEETS, R. L; VAN DE LOO, F. A. J; JOOSTEN, L. A. B et al.Arthritis and rheumatism. 2003, Vol 48, Num 10, pp 2949-2958, issn 0004-3591, 10 p.Article

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFvARAFAT, W. O; GOMEZ-NAVARRO, J; SIEGAL, G. P et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 4, pp 256-262, issn 0969-7128Article

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cellsKIM, M; ZINN, K. R; BARNETT, B. G et al.European journal of cancer (1990). 2002, Vol 38, Num 14, pp 1917-1926, issn 0959-8049Article

An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascitesBARKER, S. D; CASADO, E; CURIEL, D. T et al.Gynecologic oncology (Print). 2001, Vol 82, Num 1, pp 57-63, issn 0090-8258Article

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approachesVANDERKWAAK, T. J; MINGHUI WANG; GOMEZ-NAVARRO, J et al.Gynecologic oncology (Print). 1999, Vol 74, Num 2, pp 227-234, issn 0090-8258Conference Paper

Radiosensitization mediated by A transfected anti-erbB-2 single-chain antibody in vitro and in vivoSTACKHOUSE, M. A; BUCHSBAUM, D. J; GRIZZLE, W. E et al.International journal of radiation oncology, biology, physics. 1998, Vol 42, Num 4, pp 817-822, issn 0360-3016Conference Paper

Gene therapy and ovarian cancer : A reviewBARNES, M. N; DESHANE, J. S; ROSENFELD, M et al.Obstetrics and gynecology (New York. 1953). 1997, Vol 89, Num 1, pp 145-155, issn 0029-7844Article

Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. DiscussionROSENFELD, M. E; VICKERS, S. M; RABEN, D et al.Annals of surgery. 1997, Vol 225, Num 5, pp 609-620, issn 0003-4932Conference Paper

Efficient delivery of triplex forming oligonucleotides to tumor cells by adenovirus-polylysine complexesEBBINGHAUS, S. W; VIGNESWARAN, N; MILLER, C. R et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 4, pp 287-297, issn 0969-7128Article

Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptorSCHWARZENBERGER, P; SPENCE, S. E; GOOYA, J. M et al.Blood. 1996, Vol 87, Num 2, pp 472-478, issn 0006-4971Article

E1A RNA transcripts amplify adenovirus-mediated tumor reductionDION, L. D; GOLDSMITH, K. T; STRONG, T. V et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 11, pp 1021-1025, issn 0969-7128Article

Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozymeFENG, M; CABRERA, G; DESHANE, J et al.Cancer research (Baltimore). 1995, Vol 55, Num 10, pp 2024-2028, issn 0008-5472Article